Non-small cell lung cancer: Clinical Practice Guidelines in Oncology™

David S. Ettinger; Gerold Bepler; Raphael Bueno; Andrew Chang; Joe Y. Chang; Lucian R. Chirieac; Thomas A. D'Amico; Todd L. Demmy; Steven J. Feigenberg; Frederic W. Grannis; Thierry Jahan; Mohammad Jahanzeb; Anne Kessinger; Ritsuko Komaki; Mark G. Kris; Corey J. Langer; Quynh Thu Le; Renato Martins; Gregory A. Otterson; Francisco Robert; David J. Sugarbaker; Douglas E. Wood

doi:10.6004/jnccn.2006.0046

Non-small cell lung cancer: Clinical Practice Guidelines in Oncology™

David S. Ettinger
, Gerold Bepler
, Raphael Bueno
, Andrew Chang
, Joe Y. Chang
, Lucian R. Chirieac
, Thomas A. D'Amico
, Todd L. Demmy
, Steven J. Feigenberg
, Frederic W. Grannis
, Thierry Jahan
, Mohammad Jahanzeb
, Anne Kessinger
, Ritsuko Komaki
, Mark G. Kris
, Corey J. Langer
, Quynh Thu Le
, Renato Martins
, Gregory A. Otterson
, Francisco Robert

David J. Sugarbaker, Douglas E. Wood

School of Medicine

Research output: Contribution to journal › Review article › peer-review

129 Scopus citations

Abstract

Lung cancer is still the leading cause of cancer death worldwide, and non-small cell lung cancer accounts for 80% to 85% of all lung cancer cases. Surgery, radiation therapy, and chemotherapy are the 3 modalities commonly used to treat patients with NSCLC and can be used either alone or in combination depending on the disease status. The 2006 NCCN Non-Small Cell Lung Cancer Guidelines provide the latest updates in the management of this disease, including stage regrouping and changes in screening recommendations for high-risk patients and in treatment recommendations for several stages. In addition, principles of systemic therapy were expanded to include adjuvant treatment.

Original language	English (US)
Pages (from-to)	548-582
Number of pages	35
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	4
Issue number	6
DOIs	https://doi.org/10.6004/jnccn.2006.0046
State	Published - Jul 2006

Keywords

Chemotherapy
Lung cancer
Multimodality therapy
NCCN Clinical Practice Guidelines
Non-small cell lung cancer
Radiation therapy
Targeted therapy
Thoracic surgery

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2006.0046

Cite this

Ettinger, D. S., Bepler, G., Bueno, R., Chang, A., Chang, J. Y., Chirieac, L. R., D'Amico, T. A., Demmy, T. L., Feigenberg, S. J., Grannis, F. W., Jahan, T., Jahanzeb, M., Kessinger, A., Komaki, R., Kris, M. G., Langer, C. J., Le, Q. T., Martins, R., Otterson, G. A., ... Wood, D. E. (2006). Non-small cell lung cancer: Clinical Practice Guidelines in Oncology™. JNCCN Journal of the National Comprehensive Cancer Network, 4(6), 548-582. https://doi.org/10.6004/jnccn.2006.0046

Ettinger, DS, Bepler, G, Bueno, R, Chang, A, Chang, JY, Chirieac, LR, D'Amico, TA, Demmy, TL, Feigenberg, SJ, Grannis, FW, Jahan, T, Jahanzeb, M, Kessinger, A, Komaki, R, Kris, MG, Langer, CJ, Le, QT, Martins, R, Otterson, GA, Robert, F, Sugarbaker, DJ & Wood, DE 2006, 'Non-small cell lung cancer: Clinical Practice Guidelines in Oncology™', JNCCN Journal of the National Comprehensive Cancer Network, vol. 4, no. 6, pp. 548-582. https://doi.org/10.6004/jnccn.2006.0046

@article{12b608ae47f14c92823824b564af5024,

title = "Non-small cell lung cancer: Clinical Practice Guidelines in Oncology{\texttrademark}",

abstract = "Lung cancer is still the leading cause of cancer death worldwide, and non-small cell lung cancer accounts for 80\% to 85\% of all lung cancer cases. Surgery, radiation therapy, and chemotherapy are the 3 modalities commonly used to treat patients with NSCLC and can be used either alone or in combination depending on the disease status. The 2006 NCCN Non-Small Cell Lung Cancer Guidelines provide the latest updates in the management of this disease, including stage regrouping and changes in screening recommendations for high-risk patients and in treatment recommendations for several stages. In addition, principles of systemic therapy were expanded to include adjuvant treatment.",

keywords = "Chemotherapy, Lung cancer, Multimodality therapy, NCCN Clinical Practice Guidelines, Non-small cell lung cancer, Radiation therapy, Targeted therapy, Thoracic surgery",

author = "Ettinger, \{David S.\} and Gerold Bepler and Raphael Bueno and Andrew Chang and Chang, \{Joe Y.\} and Chirieac, \{Lucian R.\} and D'Amico, \{Thomas A.\} and Demmy, \{Todd L.\} and Feigenberg, \{Steven J.\} and Grannis, \{Frederic W.\} and Thierry Jahan and Mohammad Jahanzeb and Anne Kessinger and Ritsuko Komaki and Kris, \{Mark G.\} and Langer, \{Corey J.\} and Le, \{Quynh Thu\} and Renato Martins and Otterson, \{Gregory A.\} and Francisco Robert and Sugarbaker, \{David J.\} and Wood, \{Douglas E.\}",

year = "2006",

month = jul,

doi = "10.6004/jnccn.2006.0046",

language = "English (US)",

volume = "4",

pages = "548--582",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "6",

}

TY - JOUR

T1 - Non-small cell lung cancer

T2 - Clinical Practice Guidelines in Oncology™

AU - Ettinger, David S.

AU - Bepler, Gerold

AU - Bueno, Raphael

AU - Chang, Andrew

AU - Chang, Joe Y.

AU - Chirieac, Lucian R.

AU - D'Amico, Thomas A.

AU - Demmy, Todd L.

AU - Feigenberg, Steven J.

AU - Grannis, Frederic W.

AU - Jahan, Thierry

AU - Jahanzeb, Mohammad

AU - Kessinger, Anne

AU - Komaki, Ritsuko

AU - Kris, Mark G.

AU - Langer, Corey J.

AU - Le, Quynh Thu

AU - Martins, Renato

AU - Otterson, Gregory A.

AU - Robert, Francisco

AU - Sugarbaker, David J.

AU - Wood, Douglas E.

PY - 2006/7

Y1 - 2006/7

N2 - Lung cancer is still the leading cause of cancer death worldwide, and non-small cell lung cancer accounts for 80% to 85% of all lung cancer cases. Surgery, radiation therapy, and chemotherapy are the 3 modalities commonly used to treat patients with NSCLC and can be used either alone or in combination depending on the disease status. The 2006 NCCN Non-Small Cell Lung Cancer Guidelines provide the latest updates in the management of this disease, including stage regrouping and changes in screening recommendations for high-risk patients and in treatment recommendations for several stages. In addition, principles of systemic therapy were expanded to include adjuvant treatment.

AB - Lung cancer is still the leading cause of cancer death worldwide, and non-small cell lung cancer accounts for 80% to 85% of all lung cancer cases. Surgery, radiation therapy, and chemotherapy are the 3 modalities commonly used to treat patients with NSCLC and can be used either alone or in combination depending on the disease status. The 2006 NCCN Non-Small Cell Lung Cancer Guidelines provide the latest updates in the management of this disease, including stage regrouping and changes in screening recommendations for high-risk patients and in treatment recommendations for several stages. In addition, principles of systemic therapy were expanded to include adjuvant treatment.

KW - Chemotherapy

KW - Lung cancer

KW - Multimodality therapy

KW - NCCN Clinical Practice Guidelines

KW - Non-small cell lung cancer

KW - Radiation therapy

KW - Targeted therapy

KW - Thoracic surgery

UR - https://www.scopus.com/pages/publications/33747607482

UR - https://www.scopus.com/pages/publications/33747607482#tab=citedBy

U2 - 10.6004/jnccn.2006.0046

DO - 10.6004/jnccn.2006.0046

M3 - Review article

C2 - 16813724

AN - SCOPUS:33747607482

SN - 1540-1405

VL - 4

SP - 548

EP - 582

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 6

ER -

Non-small cell lung cancer: Clinical Practice Guidelines in Oncology™

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this